GEVORKYAN, a.s.
28.1.2026 08:00:00 CET | Globenewswire | Press release
Sintered armour
Sintered armour
GEVORKYAN, a.s. is expanding its activities in the field of defence technologies with a new development program focused on armour protection for multiple types of use. The project aims to develop solutions for the protection of both people and military equipment. The company's know-how enables it to manufacture extremely lightweight components with exceptional protective properties.
"Our goal is to provide a higher level of safety combined with extremely low weight. Today, this is a decisive parameter for the protection of everything that can fly or be carried by a person. We are pleased that in this project we are making full use of the experience of our colleagues from the Polish branch and also our presence on the Polish market," says Chairman of the Board Dipl. Ing. Artur Gevorkyan.
Modern powder metallurgy applications allow for the targeted design of material properties and microstructure, opening up possibilities for solutions that conventional manufacturing processes cannot achieve. The development of armour protection has the potential to strengthen GEVORKYAN's position in the defence sector, where demand for innovative technological solutions has long been growing.
AI-generated visualization (illustrative)
About GEVORKYAN
GEVORKYAN, a.s. is a leading European company in the field of powder metallurgy, a global supplier to large multinational companies, and one of the most innovative companies in this industry worldwide. For more information, visit www.gevorkyan.eu/en.
Contact information:
Media: Alexandra Hazuchová, marketing@gevorkyan.sk
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal Philips24.8.2026 23:04:56 CEST | Press release
Philips prices EU green bond for EUR 650M
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom